Results 11 to 20 of about 28,652 (194)
Frontiers in Pharmacology, 2022 The combination of Salvia miltiorrhiza (Danshen) and rivaroxaban is a promising treatment option in clinical practice in China, but the herb–drug interaction between Danshen and rivaroxaban remains unclear.
Xu Wang +10 more
doaj +1 more source
Rivaroxaban and retropharyngeal haemorrhage [PDF]
BMJ Case Reports, 2016 Haemorrhage is a well-known and accepted complication of anticoagulation. A retropharyngeal haemorrhage (RH) is a rare condition that without prompt recognition and management may result in fatal complications. We report a case of RH in a 67-year-old man anticoagulated with rivaroxaban for atrial fibrillation.
Jonathan Andrew McCarter +3 more
openaire +3 more sources
Journal of Prescribing Practice, 2021 In this column, Sharon Rees aims to refresh knowledge and interest in some of the commonly used drugs in a series of tweets. This month she is talking about #rivaroxaban
openaire +1 more source
Rivaroxaban versus warfarin for the management of left ventricle thrombus
The Egyptian Heart Journal, 2021 Background Rivaroxaban has been recently introduced for the management of non-valvular intra-cardiac thrombosis with variable results. We aimed to compare the results of the off-label use of rivaroxaban versus warfarin in the management of patients with ...
Monirah A. Albabtain +7 more
doaj +1 more source
Rivaroxaban in Stable Cardiovascular Disease [PDF]
New England Journal of Medicine, 2018 A response to "Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease" N Engl J Med 2017; 377:1319-1330.
Fauchier, Laurent +2 more
openaire +9 more sources
Frontiers in Pharmacology, 2023 Background: Almonertinib, a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is commonly used as a first-line treatment for non-small cell lung cancer (NSCLC) patients with EGFR T790M mutations.
Zhi Wang +6 more
doaj +1 more source
Anticoagulant effects of rivaroxaban, prednisone, alone and in combination, in healthy dogs
Journal of Veterinary Internal Medicine, 2022 Background The potential effects of glucocorticoid administration on rivaroxaban's anticoagulant bioactivity in dogs, and an appropriate rivaroxaban dosage regimen for dogs receiving glucocorticoid therapy are unknown. Hypothesis/Objectives The objective
Paige M. Hafner +4 more
doaj +1 more source
Stroke Research and Treatment, 2021 Introduction. Rivaroxaban is a new anticoagulant providing benefits for the treatment of patients with atrial fibrillation (AF). This study is aimed at evaluating the cost-effectiveness of rivaroxaban compared to warfarin in patients with AF.
Neda Jaberi +5 more
doaj +1 more source
Heart Views, 2023 Background: The use of rivaroxaban in patients with atrial fibrillation (AF) and chronic kidney disease (CKD) poses the risk of over- or underdosing. We aimed to compare rivaroxaban and warfarin in AF patients with moderate and severe renal impairment ...
Monirah Abdulrahman Albabtain +5 more
doaj +1 more source
Laboratory assessment of rivaroxaban: a review [PDF]
Thrombosis Journal, 2013 Research into new anticoagulants for preventing and treating thromboembolic disorders has focused on targeting single enzymes in the coagulation cascade, particularly Factor Xa and thrombin, inhibition of which greatly decreases thrombin generation. Based on the results of phase III clinical trials, rivaroxaban, a direct Factor Xa inhibitor, has been ...
Elisabeth Perzborn +8 more
openaire +3 more sources